Citius Oncology Inc (NASDAQ:CTOR) traded at $1.54 at close of the session on Tuesday, July 15 and made a downward move of -20.62% on its previous day’s price.
Looking at the stock we see that its previous close was $1.94 and the beta (5Y monthly) reads -0.063 with the day’s price range being $1.54 – $2.09. In terms of its 52-week price range, CTOR has a high of $49.00 and a low of $0.55. The company’s stock has gained about 4.76% over that past 30 days.
Citius Oncology Inc has a market cap of $110.19 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the CTOR stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy.
Looking further, we note the current price level is -53.23% off its SMA20 and -19.17% from its 50-day simple moving average. The RSI (14) is pointing at 36.41 while the volatility over the past week is 30.01% and jumps to 29.94% over the past one month.
Coming back to Citius Oncology Inc (NASDAQ:CTOR), we note that the average 3-month trading volume was 1.18 million, while that of the preceding 10-day period stands at 0.76 million. Current shares outstanding are 71.55 million.
The insiders hold 95.08% of the company’s shares while institutions hold 0.15%. The data shows that short shares as of 2025-06-13, stood at 0.11 million at a short ratio of 0.17. This represents a 206.00 short interest in shares outstanding on 2025-06-13. Shares short rose in June from the previous month at 47100.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -86.43% down in year-to-date price movement.
